This is an open-label, Phase 1 dose exploration study to evaluate the safety and tolerability
and to determine recommended Phase 2 dose(s) of JWCAR129, a CAR T-cell product that targets
B-cell maturation antigen (BCMA), in adult subjects with relapsed and/or refractory multiple
Safety and Efficacy
Clinical Study Identifier
The First Affiliated Hospital of Soochow University
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.